MontaƱez, Exsiquel .

HRN: 28-96-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/09/2026
05/15/2026
IV
4.5gm LD Then 2.25gm Q6
Q6
UTI
Checking Initial Appropriateness 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines